Please find attached press release on unaudited financial results for the quarter and half year ended September 30, 2026

~ GALAXY Chemistry Creates Care November 04, 2026 National Stock Exchange of India Limited, BSE Limited, Listing Compliance Department Listing Department, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra (East) Mumbai- 400001 Mumbai – 400 051 Scrip Symbol: GALAXYSURF Scrip Code: 540935 Sub: Press release on the unaudited financial results for quarter and half year ended September 30, 2026. Ref: Regulation 30 (2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, We are enclosing press release on the unaudited financial results for the quarter and half year ended September 30, 2026. The information will also be hosted in announcement section on the website of the Company at www.galaxysurfactants.com. We request you to take the same on record. Yours faithfully, For Galaxy Surfactants Limited Niranjan Ketkar Company Secretary encl: as above Galaxy Surfactants Ltd. Regd. Office: C-49/2, TTC Industrial Area, Pawne, Navi Mumbai 400 703 P +91-22-39135500 F +91-39135554 E galaxy@galaxysurfactants.com www.galaxysurfactants.com CIN No. L39877MH1986PLC039877 Chemistry CreatesCa ~ Chemistry Creates Care Investors Release Galaxy Surfactants Limited Q2FY27 Consolidated Performance Robust Earnings Momentum Driven by Volume Growth and a Richer Specialty Care portfolio mix Total Revenue EBITDA PAT ₹ 1,816.8 cr ₹ 195.9 cr ₹ 119.8 cr 36.4% YoY 68.4% YoY 80.1% YoY Navi Mumbai, 4th November 2026: Galaxy Surfactants Limited, a leading manufacturer of performance surfactants and specialty care products with over 215+ product grades used in the Home and Personal Care industry, has announced its financial results for the quarter and half year ended 30th September 2026. Key Developments • Consolidated volumes registered high-single-digit growth on YoY, driven by strong mid-teens growth in India and AMET regions reflecting resilient customer demand and strong execution • EBITDA grew by 68% YoY to ₹196 crore, while EBITDA/MT increased by 56% to ₹26,920/MT, driven by volume-led growth, an improved Specialty Care mix, and sustained demand for premium and masstige offerings across domestic and international markets. • In Rest of the World markets, volumes did get affected due to logistics disruptions and elevated freight costs; however demand for premium and masstige Specialty Care products remained healthy. Chemistry CreatesCa ~ Chemistry Creates Care Investors Release Commenting on the performance Mr. K. Natarajan, Managing Director, Galaxy Surfactants Limited, “We are pleased with the strong performance delivered in Q2 FY27. The broad-based growth in India, continued recovery in AMET and sustained momentum in Specialty Care demonstrate the strength and resilience of our business. Our ability to make disciplined commercial decisions and leverage our diversified portfolio has enabled us to deliver a robust performance despite a challenging external environment. The performance over the last two quarters also reflects the exceptional efforts and collaboration of our teams across business development, commercial excellence, procurement, global logistics, manufacturing and operations. Their agility, commitment and focused execution have ensured business continuity amid significant external disruptions. With an improving business mix and continued momentum in Specialty Care, we remain confident in delivering sustainable and profitable growth. Importantly, PAT for the first six months of FY27 has already surpassed the PAT delivered for the entire previous financial year, making a significant milestone for the company. Demand indicators remain encouraging across key markets, with healthy consumption trends in India, improving conditions in AMET and positive Specialty Care demand across geographies. The Company remains vigilant regarding developments in West Asia and their potential implications for global logistics, freight rates and feedstock availability.” Consolidated Performance Highlights Particulars (₹ In Crores) Q2FY27 Q2FY26 Y-o-Y H1FY27 H1FY26 Y-o-Y FY26 Total Revenue 1,816.8 1,332.0 36.4% 3,602.0 2,621.1 37.4% 5,270.4 EBITDA 195.9 116.3 68.4% 448.4 251.4 78.4% 497.4 EBITDA Margin 10.8% 8.7% 12.4% 9.6% 9.4% PAT 119.8 66.5 80.1% 285.7 146.0 95.7% 267.4 PAT Margin 6.6% 5.0% 7.9% 1.2% 5.1% Chemistry CreatesCa ~ Chemistry Creates Care Investors Release Sales Volume Summary on YoY Regions Q2FY27 H1FY27 India Mid-Teens Growth Mid-Teens Growth AMET Mid-Teens Growth Mid-Single Digit Growth ROW High Single Digit Decline Flat Overall High Single Digit Volume Growth on YoY Regions Q2FY27 H1FY27 Performance Surfactant Mid-Teens Growth High Single Digit Growth Specialty Care Flat Low Single Digit Growth Overall High Single Digit Volume Growth on YoY Category wise Revenue Summary Particulars (₹ in cr) Q2FY27 H1FY27 Performance Surfactant 1,175 2,304 Specialty Care 635 1,288 Total 1,810 3,592 Chemistry CreatesCa ~ Chemistry Creates Care Investors Release About Galaxy Surfactants Limited: Incorporated in 1986, Galaxy Surfactants Ltd is a leading manufacturer of Performance Surfactants and Specialty Care products with over 215 product grades. These products are used in consumer-centric Home and Personal care products like hair care, oral care, skincare, cosmetics, soap, shampoo, lotion, detergent, cleaning products etc. Preferred suppliers to leading MNC’s, Regional and Local FMCG brands. Our key customers include Unilever, Reckitt Benckiser, P&G, L’OREAL, Himalaya, Colgate Palmolive, CavinKare etc. Company has its manufacturing facilities located in India (5), Egypt (1) and USA (1). For more information about the company, please visit our website www.galaxysurfactants.com Safe Harbor: Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. The company assumes no obligation to update forward-looking statements to reflect actual results changed assumptions or other factors. For further details please contact: Company Investor Relations Advisors Galaxy Surfactants Ltd. Strategic Growth Advisors Pvt. Ltd. CIN No: L39877MH1986PLC039877 CIN No: U74140MH2010PTC204285 Name: Mr. Ruchir Soni Mr. Mandar Chavan / Mr. Rahul Agarwal Email id: Ruchir.Soni@galaxysurfactants.com Email id: mandar.chavan@sgapl.net / rahul.agarwal@sgapl.net Tel No: +91 96993 82195 / +91 98214 38864